GEODE CAPITAL MANAGEMENT, LLC - REGULUS THERAPEUTICS INC ownership

REGULUS THERAPEUTICS INC's ticker is and the CUSIP is 75915K309. A total of 29 filers reported holding REGULUS THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of REGULUS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$169,142
+2.2%
122,521
+8.8%
0.00%
Q2 2023$165,554
+162.0%
112,622
+51.0%
0.00%
Q1 2023$63,200
+61860.8%
74,5730.0%0.00%
Q4 2022$102
-99.9%
74,573
+3.8%
0.00%
Q3 2022$122,000
-17.6%
71,8570.0%0.00%
Q2 2022$148,00071,8570.00%
Other shareholders
REGULUS THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 555,555$470,8330.14%
Sarissa Capital Management LP 185,183$156,9430.02%
FEDERATED HERMES, INC. 2,904,826$2,463,2920.01%
VANGUARD GROUP INC 282,660$239,5540.00%
VICTORY CAPITAL MANAGEMENT INC 221,506$187,7260.00%
JANE STREET GROUP, LLC 18,189$15,4150.00%
UBS Group AG 1,738$1,4740.00%
Community Bank, N.A. 690$5790.00%
OSAIC HOLDINGS, INC. 50$420.00%
FMR LLC 4,390,000$3,720,5260.00%
View complete list of REGULUS THERAPEUTICS INC shareholders